Ali, Azhar A.
Clary, Chadd W.
Smoger, Lowell M.
Dennis, Douglas A.
Fitzpatrick, Clare K.
Rullkoetter, Paul J.
Laz, Peter J. http://orcid.org/0000-0003-1013-2077
Funding for this research was provided by:
National Science Foundation (CBET-1034251)
Foundation for the National Institutes of Health (1R01EB015497-01)
DePuy Synthes
Article History
Received: 2 July 2019
Accepted: 20 January 2020
First Online: 4 February 2020
Compliance with ethical standards
:
: For the population model, the study used cadaveric data, publically available data from the Osteoarthritis Initiative and de-identified data, and was categorized as exempt by the University of Denver Institutional Review Board. With regard to the implant size data for the clinical subjects, the study (ID: 1480194-1) was reviewed and approved by the Catholic Health Initiatives Institute for Research and Innovation Institutional Review Board (CHIRB). The implant size data were deidentified, and no patient information was transferred.
: Disclosures for the authors are as follows: A.A. Ali, L.M. Smoger and C.K. Fitzpatrick have no conflicts of interest to report. P.J. Laz, C.W. Clary and P.J. Rullkoetter have received institutional support from DePuy Synthes. C.W. Clary and P.J. Rullkoetter have served as consultants for DePuy Synthes. D.A. Dennis has received royalties from DePuy Synthes and Innomed, and received honorariums and served as a consultant for DePuy Synthes and Corin. He reports owning stock or stock options in Joint Vue and receiving research or institutional support from DePuy Synthes and Porter Adventist Hospital.